Publications

Targeted degradation of oncogenic KRAS G12V triggers antitumor immunity in lung cancer models

 84
Targeted degradation of oncogenic KRAS G12V triggers antitumor immunity in lung cancer models

Tags:

Previous Article

Increased cholesterol synthesis drives neurotoxicity in multiple sclerosis

Next Article

Animal model for antitumor immunity in lung cancer

Related Posts

Phosphorylation by JNK switches BRD4 functions

Phosphorylation by JNK switches BRD4 functions

 72

Human MASLD is a diurnal disease driven by multisystem insulin resistance and reduced insulin availability at night

Human MASLD is a diurnal disease driven by multisystem ...

 108

Viral mimicry in cancer therapy

Viral mimicry in cancer therapy

 69